July 4, 2017
Makoto Kinoshita, chairman of the JAS’s epidemiology and clinical management of atherosclerosis committee The Japan Atherosclerosis Society (JAS) has issued its guidelines for the prevention of atherosclerotic diseases 2017. Regarding PCSK9 inhibitors, which are novel treatments for dyslipidemia, the guidelines...read more